Junpei Homma

631 total citations
8 papers, 474 citations indexed

About

Junpei Homma is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Junpei Homma has authored 8 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Junpei Homma's work include Immunotherapy and Immune Responses (5 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Junpei Homma is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Junpei Homma collaborates with scholars based in Japan and United States. Junpei Homma's co-authors include Ryuya Yamanaka, Naoki Yajima, Naoto Tsuchiya, Ryuichi Tanaka, Masakazu Sano, Masuhiro Takahashi, Seiichi Yoshida, Tsutomu Kobayashi, Takashi Abe and Miwako Narita and has published in prestigious journals such as Clinical Cancer Research, Molecular Therapy and Cancer Immunology Immunotherapy.

In The Last Decade

Junpei Homma

8 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junpei Homma Japan 7 285 234 164 138 45 8 474
Julia D. Mellentin United States 7 92 0.3× 68 0.3× 349 2.1× 67 0.5× 29 0.6× 7 578
Stephen Muth United States 13 285 1.0× 369 1.6× 197 1.2× 19 0.1× 24 0.5× 18 624
Michimasa Ebato Japan 10 160 0.6× 109 0.5× 76 0.5× 135 1.0× 66 1.5× 16 325
Anna Kuta United Kingdom 12 180 0.6× 184 0.8× 203 1.2× 51 0.4× 62 1.4× 13 543
Brian M. Andersen United States 10 240 0.8× 127 0.5× 116 0.7× 119 0.9× 15 0.3× 10 385
Agnė Petrošiūtė United States 6 160 0.6× 189 0.8× 129 0.8× 36 0.3× 15 0.3× 15 417
Marie‐Aude Le Bitoux Switzerland 5 114 0.4× 165 0.7× 384 2.3× 77 0.6× 9 0.2× 8 592
David Hou United States 8 277 1.0× 264 1.1× 167 1.0× 127 0.9× 6 0.1× 13 536
Alicia Y. Hou United States 3 160 0.6× 293 1.3× 108 0.7× 35 0.3× 11 0.2× 5 396
Stef van Lieshout Netherlands 7 76 0.3× 91 0.4× 243 1.5× 34 0.2× 14 0.3× 11 519

Countries citing papers authored by Junpei Homma

Since Specialization
Citations

This map shows the geographic impact of Junpei Homma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junpei Homma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junpei Homma more than expected).

Fields of papers citing papers by Junpei Homma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junpei Homma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junpei Homma. The network helps show where Junpei Homma may publish in the future.

Co-authorship network of co-authors of Junpei Homma

This figure shows the co-authorship network connecting the top 25 collaborators of Junpei Homma. A scholar is included among the top collaborators of Junpei Homma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junpei Homma. Junpei Homma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Yamanaka, Ryuya, Ken Morii, Yoko Shinbo, et al.. (2008). Results of Treatment of 112 Cases of Primary CNS Lymphoma. Japanese Journal of Clinical Oncology. 38(5). 373–380. 17 indexed citations
2.
Homma, Junpei, Shigeki Kameyama, Hiroshi Masuda, et al.. (2007). Stereotactic radiofrequency thermocoagulation for hypothalamic hamartoma with intractable gelastic seizures. Epilepsy Research. 76(1). 15–21. 51 indexed citations
3.
Sano, Masakazu, Naoki Yajima, Naoto Tsuchiya, et al.. (2006). Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncology Reports. 16(5). 1093–8. 61 indexed citations
4.
Yamanaka, Ryuya, Junpei Homma, Naoki Yajima, Masakazu Sano, & Masuhiro Takahashi. (2006). 277. Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial. Molecular Therapy. 13. S106–S106. 15 indexed citations
5.
Yamanaka, Ryuya, Junpei Homma, Naoki Yajima, et al.. (2005). Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial. Clinical Cancer Research. 11(11). 4160–4167. 259 indexed citations
6.
Kobayashi, Tsutomu, Ryuya Yamanaka, Junpei Homma, et al.. (2003). Tumor mRNA?loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma. Cancer Immunology Immunotherapy. 52(10). 632–637. 40 indexed citations
7.
Yamanaka, Ryuya, Naoki Yajima, Takashi Abe, et al.. (2003). Dendritic cell-based glioma immunotherapy (Review). International Journal of Oncology. 23(1). 5–15. 30 indexed citations
8.
Yamanaka, Ryuya, Junpei Homma, Naoki Yajima, Naoto Tsuchiya, & Ryuichi Tanaka. (2003). [Dendritic cell therapy for malignant glioma].. PubMed. 55(9). 771–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026